Journal article icon

Journal article

Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent.

Abstract:

Aims: The EVOLVE FHU trial demonstrated non-inferiority of six-month late loss with two dose formulations of SYNERGY, a novel bioabsorbable polymer everolimus-eluting stent (EES) compared with the durable polymer PROMUS Element (PE) EES. The current analysis describes the six-month IVUS and clinical results through two years from the EVOLVE FHU trial. Methods and results: EVOLVE recruited 291 patients from 29 centres. At six months, IVUS-assessed in-stent net volume obstruction was 3.40±5.06%...

Expand abstract

Actions


Access Document


Publisher copy:
10.4244/EIJV9I3A52

Authors


Journal:
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology More from this journal
Volume:
9
Issue:
3
Pages:
308-315
Publication date:
2013-05-01
DOI:
EISSN:
1969-6213
ISSN:
1774-024X
Language:
English
Keywords:
Pubs id:
pubs:402055
UUID:
uuid:d387cbc1-f1f9-4d31-9ff6-50e3622949d5
Local pid:
pubs:402055
Source identifiers:
402055
Deposit date:
2014-08-22

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP